Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP128661.RAZMMme46zEdU9BS8_sOrxXlxAaGB7T7teeuI42YFSKM0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP128661.RAZMMme46zEdU9BS8_sOrxXlxAaGB7T7teeuI42YFSKM0130_assertion type Assertion NP128661.RAZMMme46zEdU9BS8_sOrxXlxAaGB7T7teeuI42YFSKM0130_head.
- NP128661.RAZMMme46zEdU9BS8_sOrxXlxAaGB7T7teeuI42YFSKM0130_assertion description "[In individual single nucleotide polymorphism analysis, after adjustment for multiple comparisons, a significantly decreased RCC risk was observed for the heterozygous genotype of XPD Asp312Asn odds ratio (OR) = 0.62; 95% confidence interval (CI): 0.43-0.90 and for the heterozygous and homozygous variant genotypes combined in a dominant model (OR = 0.64; 95% CI: 0.46-0.89).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP128661.RAZMMme46zEdU9BS8_sOrxXlxAaGB7T7teeuI42YFSKM0130_provenance.
- NP128661.RAZMMme46zEdU9BS8_sOrxXlxAaGB7T7teeuI42YFSKM0130_assertion evidence source_evidence_literature NP128661.RAZMMme46zEdU9BS8_sOrxXlxAaGB7T7teeuI42YFSKM0130_provenance.
- NP128661.RAZMMme46zEdU9BS8_sOrxXlxAaGB7T7teeuI42YFSKM0130_assertion SIO_000772 18711149 NP128661.RAZMMme46zEdU9BS8_sOrxXlxAaGB7T7teeuI42YFSKM0130_provenance.
- NP128661.RAZMMme46zEdU9BS8_sOrxXlxAaGB7T7teeuI42YFSKM0130_assertion wasDerivedFrom gad-20150221 NP128661.RAZMMme46zEdU9BS8_sOrxXlxAaGB7T7teeuI42YFSKM0130_provenance.
- NP128661.RAZMMme46zEdU9BS8_sOrxXlxAaGB7T7teeuI42YFSKM0130_assertion wasGeneratedBy ECO_0000203 NP128661.RAZMMme46zEdU9BS8_sOrxXlxAaGB7T7teeuI42YFSKM0130_provenance.